<p><em>NR5A2</em> Promotes Cell Growth and Resistance to Temozolomide Through Regulating Notch Signal Pathway in Glioma</p>-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

NR5A2 Promotes Cell Growth and Resistance to Temozolomide Through Regulating Notch Signal Pathway in Glioma

Published:2020-10 Issue: Volume:Volume 13 Page:10231-10244
ISSN:1178-6930
Container-title:OncoTargets and Therapy
language:en
Short-container-title:OTT

Author:

Yang Quanxi,Deng Lei,Li Jialiang,Miao Pengfei,Liu Wenxiang,Huang Qi

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Reference38 articles.

1. Survivorship in adults with malignant brain and other central nervous system tumor from 2000–2014

2. Epidemiology and molecular pathology of glioma

3. Cancer statistics in China, 2015

4. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NR5A2 gene affects the overall survival of LUAD patients by regulating the activity of CSCs through SNP pathway by OCLR algorithm and immune score;Heliyon;2024-04

2. NR5A2 promotes malignancy progression and mediates the effect of cisplatin in cutaneous squamous cell carcinoma;Immunity, Inflammation and Disease;2024-02

3. MicroRNA‐433‐3p enhances chemosensitivity of glioma to cisplatin by downregulating NR5A2;Brain and Behavior;2022-10-27

4. Integrin subunit alpha V is a potent prognostic biomarker associated with immune infiltration in lower-grade glioma;Frontiers in Neurology;2022-10-25

5. Purple sweet potato delphinidin-3-rutin represses glioma proliferation by inducing miR-20b-5p/Atg7-dependent cytostatic autophagy;Molecular Therapy - Oncolytics;2022-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3